Medifocus Inc. | Income Statement
Fiscal year is April-March. All values CAD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
5,384.00
4,802.20
5,949.50
4,966.80
3,422.80
Cost of Goods Sold (COGS) incl. D&A
6,062.10
4,160.30
4,272.80
3,017.70
2,302.80
Gross Income
678.10
641.90
1,676.70
1,949.10
1,120.00
SG&A Expense
4,178.70
5,294.50
5,897.00
2,620.30
2,045.60
EBIT
4,856.80
4,652.60
-
406.00
884.70
Unusual Expense
741.90
319.00
332.10
109.20
0.70
Non Operating Income/Expense
11.00
207.40
13.40
191.80
13.60
Interest Expense
365.60
1,553.80
1,828.40
1,737.10
1,106.40
Pretax Income
5,975.30
6,796.20
6,509.20
2,060.50
1,978.20
Equity in Affiliates
159.00
-
-
-
-
Consolidated Net Income
6,134.30
6,796.20
6,509.20
2,060.50
1,978.20
Net Income
6,134.30
6,796.20
6,509.20
2,060.50
1,978.20
Net Income After Extraordinaries
6,134.30
6,796.20
6,509.20
2,060.50
1,978.20
Net Income Available to Common
6,134.30
6,796.20
6,509.20
2,060.50
1,978.20
EPS (Basic)
0.05
0.06
0.02
0.01
0.01
Basic Shares Outstanding
117,260.40
122,809.90
164,702.00
184,984.20
184,984.20
EPS (Diluted)
0.05
0.06
0.04
0.01
0.01
Diluted Shares Outstanding
117,260.40
122,809.90
164,702.00
184,984.20
184,984.20
EBITDA
4,473.50
4,241.50
4,020.50
70.10
406.10
Other Operating Expense
-
-
273.10
265.30
40.90
Equity in Affiliates (Pretax)
-
63.40
131.20
-
-
About Medifocus
View Profile
